Remove 2004 Remove Clinical Trials Remove Computational Chemistry
article thumbnail

How the AI revolution can accelerate early drug discovery

Drug Target Review

How AI/ML technology has accelerated drug discovery Although AI for drug discovery (AIDD) can be viewed as being in the initial phases of development and acceptance, compounds discovered using AIDD platforms are already entering clinical trials. Matthew subsequently put his computational chemistry skills to use in the defence sector.

Drugs 105
article thumbnail

Sygnature Discovery accelerates global growth with major North American acquisition

Sygnature Discovery

Founded in 2011, NuChem Sciences delivers expert integrated and standalone discovery solutions across medicinal, synthetic, scale-up, process and computational chemistry, as well as DMPK, in vitro biology and in vivo pharmacology.